EVIDENCE LIBRARY
Browse source-supported forensic toxicology guides in this subject area.
Oct 20, 2026
Yun et al. tested mouse conditioned place preference, rat IV self-administration and isolated synaptosome dopamine. Learn actual N, dose limits and why this is not human blood impairment evidence.
Read guideOct 20, 2026
A 43-person lisdexamfetamine trial lowered self-reported cocaine craving but did not significantly reduce urine benzoylecgonine positivity in all randomized patients.
Read guideOct 20, 2026
A 16-child randomized lisdexamfetamine crossover trial after traumatic brain injury: attention findings, conflicting CPT statistics, null scales, anxiety and absent blood assays.
Read guideOct 20, 2026
Rat plasma d-amphetamine at roughly 44–102 ng/mL aligned with attention gains in a separate behavioral group—not a human whole-blood impairment cutoff.
Read guideOct 20, 2026
Original trial analysis: 76 Japanese children with ADHD, three lisdexamfetamine target doses, an early null result, adverse events and forensic limits.
Read guideOct 20, 2026
In a 32-adult randomized trial, lisdexamfetamine improved ADHD ratings but not CO-verified smoking abstinence versus nicotine patches and placebo. Source data and limits.
Read guideOct 20, 2026
Original study: 19/158 cocaine forehead swabs vs 10/158 hair positive; skin contact can persist, so a swab cannot prove ingestion, impairment or use time.
Read guideOct 20, 2026
In 161 randomized adults, lisdexamfetamine improved six tested AIM-A domains; AAQoL differences were descriptive. No forensic drug blood levels or driver testing.
Read guideOct 20, 2026
A 24-person trial found delayed plasma amphetamine after lisdexamfetamine, but similar modeled peak, exposure and drug liking. Understand forensic limits.
Read guideOct 20, 2026
A 44-adult randomized study did not prove mixed amphetamine salts noninferior to modafinil on Epworth scores (p=.11), despite selected secondary results.
Read guide